Abstract
Noonan syndrome (NS) is an autosomal dominant disease characterized by postnatal short stature, facial dimorphisms, congenital heart disease and thoracic deformity. Germline mutations found in components of the RAS/MAPK signaling pathway have been described in patients with NS and other rare syndromes whose phenotype overlaps the SN, explaining the molecular cause in about 75 % of cases. …